The use of exogenous steroids in septic shock is a controversial issue with inconsistent data on mortality to date. Several studies examine sepsis treatment. What does the evidence show?
The ADRENAL trial was designed to test the hypothesis that hydrocortisone results in lower mortality than placebo among patients with septic shock. Find out what investigators discovered.
Ischemic stroke is one of the most common causes of death and devastating permanent disability worldwide. Two new trials - DAWN and DEFUSE 3 - suggest endovascular therapy could benefit patients prese